SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-24-011626
Filing Date
2024-08-08
Accepted
2024-08-08 16:32:12
Documents
15
Period of Report
2024-08-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K hook-20240808x8k.htm   iXBRL 8-K 37342
2 EX-99.1 hook-20240808xex99d1.htm EX-99.1 119573
3 GRAPHIC hook-20240808xex99d1001.jpg GRAPHIC 15457
  Complete submission text file 0001558370-24-011626.txt   315628

Data Files

Seq Description Document Type Size
4 EX-101.SCH hook-20240808.xsd EX-101.SCH 3280
5 EX-101.LAB hook-20240808_lab.xml EX-101.LAB 16577
6 EX-101.PRE hook-20240808_pre.xml EX-101.PRE 10463
17 EXTRACTED XBRL INSTANCE DOCUMENT hook-20240808x8k_htm.xml XML 4977
Mailing Address 350 FIFTH AVENUE, 72ND FLOOR, SUITE 7240 NEW YORK NY 10118
Business Address 350 FIFTH AVENUE, 72ND FLOOR, SUITE 7240 NEW YORK NY 10118 0114318906360
HOOKIPA Pharma Inc. (Filer) CIK: 0001760542 (see all company filings)

IRS No.: 815395687 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38869 | Film No.: 241189014
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)